Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

INTRODUCTION: Metastatic colorectal cancer is rarely curable. Improving quality of life is therefore a key treatment goal. We report quality of life for patients with RAS wild-type metastatic colorectal cancer in the PRIME study. METHODS: A randomised phase 3 open-label study of first-line panitumum...

Descripción completa

Detalles Bibliográficos
Autores principales: Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070244/
https://www.ncbi.nlm.nih.gov/pubmed/27843597
http://dx.doi.org/10.1136/esmoopen-2016-000041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070244/
https://www.ncbi.nlm.nih.gov/pubmed/27843597
http://dx.doi.org/10.1136/esmoopen-2016-000041

Ejemplares similares